企業プロフィール
ImmunoGen 株価・ニュース・カタリスト
- ティッカー:
- IMGN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for IMGN.
企業概要
事業概要
ImmunoGen was an antibody-drug conjugate company focused on oncology before being acquired by AbbVie.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ prior to acquisition, it sat in oncology biotechnology.
ビジネスモデルの特徴
The business was driven by ADC development, commercial execution, and the value of its tumor-targeting payload platform.
バイオ業界での位置付け
ImmunoGen was one of the defining ADC names and now belongs to biotech M&A history.
今後のカタリスト
- ImmunoGen is now mainly a closeout / integration story after the AbbVie transaction, so the catalysts are any remaining corporate or settlement steps rather than a live pipeline event. The market is focused on residual value and final integration details.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。